New York – – September 29, 2026 -- Deloitte analysis projects that shifting U.S. healthcare from reactive treatment to proactive, life-stage-aware care could generate $527 billion in additional potential spending on women's health by 2030 compared with a baseline trajectory.

Washington, D.C. – September 29, 2026 -- LUNGevity Foundation has committed $2 million to fund two three-year clinical research projects aimed at improving the diagnosis of indeterminate pulmonary nodules (IPNs), a condition affecting more than 1.5 million Americans annually after routine chest CT scans.

Espoo – September 29, 2026 -- Valmet Oyj's Board of Directors has confirmed that the second instalment of its 2025 dividend, EUR 0.67 per share, will be paid on October 7, 2026.

Shareholders on record October 1 qualify for payout

The dividend will go to shareholders registered in Valmet's shareholders' register held by Euroclear Finland Oy on the record date of October 1, 2026.

Oslo, Norway – September 29, 2026 -- Nel ASA has secured a purchase order worth approximately USD 12 million from Collins Aerospace for PEM electrolyser stacks destined for US Navy submarine life-support systems. The order was placed through Nel Hydrogen US, a subsidiary of the Oslo-listed hydrogen technology company (OSE: NEL).

Amsterdam – September 29, 2026 -- Nearly $300 million in European spend has now moved through Arkestro's predictive procurement platform, with regional volume growing 93% year over year, the company announced at DPW Amsterdam 2026.

Irvine, Calif. – – September 29, 2026 -- Performance Brokerage Services has brokered the sale of Genesis of Glenview, Illinois, to Joe Ghaben, adding a fifth franchise point to the Chicago-area Ghaben Auto Group.

Ghaben Auto Group expands Chicago footprint with Genesis acquisition

Ghaben Auto Group, founded in 2004, already operates Volkswagen of Oak Lawn, Volkswagen of Orland Park, and the two-location Ultimo Motors luxury pre-owned brand in Northbrook and Westmont. The Genesis acquisition marks the group's entry into the Genesis franchise network.

Shanghai – – September 29, 2026 -- Hengrui Pharma has licensed its investigational obesity and diabetes drug HRS-1596 to Novo Nordisk in a deal worth up to 2.6 billion US dollars, including a 300 million dollar upfront payment.

Shanghai – – September 29, 2026 -- Zoomlion Heavy Industry Science & Technology Co., Ltd. has signed a US$300 million portfolio credit insurance policy alongside an initial US$50 million non-recourse factoring agreement, creating a tiered financing structure for the company's overseas installment receivables. The deals were finalized at the Zoomlion 2026 Global Financial Partners Summit in Shanghai on September 11.

Copenhagen – September 29, 2026 -- NKT used its Investor Day 2026 in Karlskrona, Sweden, to unveil a formal capital allocation framework and confirm that commercial operation at its expanded Karlskrona facility will begin in Q2 2027, slightly ahead of the original schedule.

St. Helier – September 29, 2026 -- Petrus Advisers, which holds roughly 3.8% of Iveco Group N.V. shares, has publicly rejected Tata Motors' all-cash voluntary tender offer of €14.10 per share, arguing the bid fails to reflect fair value for Iveco shareholders.